Danish 82c trial
WebApr 9, 2024 · 乳腺癌改良根治术后放疗靶区勾画.ppt WebBetween 1982 and 1990, postmenopausal women with high-risk breast cancer (stage II or III) were randomly assigned adjuvant tamoxifen (30 mg daily for 1 year) alone (689) or …
Danish 82c trial
Did you know?
WebThe trial protocol, available at NEJM.org, was approved by the regional scientific ethics committee for the Capital Region of Denmark and the Danish Data Protection Agency. The trial was performed ... WebAug 28, 2016 · Principal Findings: The primary outcome, incidence of all-cause mortality, occurred in 21.6% of the ICD group versus 23.4% of the control group (p = 0.28). Younger patients (<59 years) appeared to derive greater benefit from ICD implantation versus older patients (p for interaction = 0.009). Sudden cardiac death: 4.3% versus 8.2%; …
Weband overall survival rate. The Danish 82b trial noted an improvement in overall survival at 10 years (54% versus 45%, P <.001) in premenopausal women with high-risk disease who had received CMF (cyclophos-phamide, methotrexate, fluorouracil) chemotherapy, whereas the Danish 82c trial noted a somewhat simi-lar improvement in postmenopausal women ... WebJan 12, 2024 · NSABP-B06 (1976–1980) 25-Year follow-up of a randomized trial of 590, 632, and 629 patients treated with mastectomy, lumpectomy alone, or lumpectomy followed by adjuvant RT Cumulative incidence of …
WebDec 9, 2024 · During a median follow-up of 9.5 years (compared with 5.6 years in the original DANISH trial), ICD implantation did not provide an overall long-term survival benefit. However, patients ≤70 years in the … WebFeb 10, 2015 · Supporting this concern, we noticed that the CSS curves diverge very early for the high-risk patient group, whereas in the Danish 82c trial, which enrolled patients with higher risk of breast cancer, the survival benefit from RT was not appeared until 5 years after treatment.15 The early divergence of the CSS curves in our high-risk subgroup ...
WebThe role of postmastectomy irradiation together with systemic treatment was evaluated in high-risk patients included in the Danish Breast Cancer Cooperative Group (DBCG) protocol 82. As of June 1989, a total of 1473 pre- and menopausal patients were randomized to postmastectomy irradiation + CMF ver …
WebTrial Oversight. The Danish Study to Assess the Efficacy of ICDs in Patients with Non-ischemic Systolic Heart Failure on Mortality (DANISH) was an investigator-initiated multicenter, randomized ... lights on cotton rock绘本WebNov 1, 2001 · On the heels of those influential papers, Dr. Marie Overgaard et al. has published another Danish trial regarding the benefits of RT on survival in high risk … lights on cotton rock spaceshipWebMay 15, 1999 · Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c … lights on curtain rodWebIn Postmenopausal Danish Trial 82c, as in Premenopausal Danish Trial 82b, inadequate surgical Tx of the axilla resulted in a median of only 7 axillary LNs removed at surgery. A suboptimal duration of tamoxifen was also employed (1 yr vs. the typical 5 yrs). lights on dashboardWebApr 13, 2004 · As well, in the Danish 82c trial, 1 year of tamoxifen therapy was used, as opposed to the current standard of 5 years of tamoxifen therapy. In the Danish 82b trial and the British Columbia trial, CMF chemotherapy was used,5, 6 as opposed to anthracycline chemotherapy currently in common use.42 lights on cotton rock storyWebWhat was the study population in the EORTC boost trial? stage 1-2 (T1-2, N0-1), WLE with 1 cm gross margin, ALND, 5569 pts (251 (+) margins) ... What was the chemotherapy used in the Danish 82c study? Tam: 30 daily x 1yr starting 2-4 weeks post-op. Chemo: CMF q4wk x 8 (if RT) or x 9 (no RT). lights on dashWebThe Danish 82b and 82c trials were included node-negative patients who were eligible for this trial due to the presence of high-risk factors as invasion of pectoralis muscle or skin … pear orchard kingston seymour